Healrna was evaluated as a municipal - level enterprise technology center in Suzhou.

In accordance with the "Trial Measures for the Recognition and Management of Suzhou Municipal Technology Centers" (Sufu [1997] No. 115), the Suzhou Municipal Bureau of Industry and Information Technology organized the application for the 2023 municipal enterprise technology centers throughout the city, focusing on key areas of the province's "1650" industrial system and our city's advanced manufacturing clusters, as well as local characteristic and advantageous products. Following local recommendations, preliminary third-party review, material supplementation and improvement, re-examination, and deliberation by the Party group meeting, Healrna was recognized as the 27th batch of Suzhou Municipal Enterprise Technology Centers.

The evaluation criteria for Suzhou Enterprise Technology Centers are exceedingly rigorous, demanding that enterprises meet a series of high standards in technology research and development, innovation capabilities, and the transformation of scientific and technological achievements. Achieving this honor, on the one hand, demonstrates that Healrna has made remarkable achievements in technological strength and innovation capabilities. Enterprise Technology Centers are not only crucial platforms for enterprises' own scientific and technological innovation but also significant engines for local economic development.

As a company dedicated to biomedical research and development, Healrna has consistently regarded innovation as the core driving force for its development. Through continuously increasing R&D investment, we have achieved a series of significant breakthroughs in the mRNA field. Being recognized as a Suzhou Enterprise Technology Center is not only an acknowledgment of Healrna's past achievements but also an expectation for its future development.

In the future, Healrna will further leverage the platform advantages of the Technology Center, strengthen cooperation with research institutions and universities, deepen technological innovation, and enhance core competitiveness. Simultaneously, Huiliao Bio will increase the transformation of scientific and technological achievements, promoting the conversion of more scientific research results into actual productivity, and injecting more innovative momentum into Suzhou's biomedical industry.